Springer Nature
Browse
12882_2016_382_MOESM2_ESM.pdf (67.64 kB)

Additional file 2: Figure S1. of Facility-level CKD-MBD composite score and risk of adverse clinical outcomes among patients on hemodialysis

Download (67.64 kB)
journal contribution
posted on 2016-11-04, 05:00 authored by Geoffrey Block, Akeem Yusuf, Mark Danese, Heidi Wirtz, Yan Hu, Thy Do, Kerry Cooper, David Gilbertson, Brian Bradbury, Allan Collins
Relative risks and 95 % confidence intervals for risk of adverse clinical events associated with quintile of facility-level proportions of patients with at least two of three CKD-MBD biomarkers out of or above target ranges, using a PTH target range of 150–300 pg/mL. CKD-MBD, chronic kidney disease-mineral bone disorder; PTH, parathyroid hormone. (PDF 67 kb)

Funding

Amgen

History

Usage metrics

    BMC Nephrology

    Categories

    Keywords

    Chronic kidney disease-mineral bone disorderEnd-stage renal diseaseHemodialysis

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC